Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 3
1(33.3%)
3Total
N/A(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT03188796Phase 3Recruiting

The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill Patients

Role: collaborator

NCT06553261Recruiting

Anastomotic Leakage in Right Colectomy

Role: lead

NCT04205006Unknown

Stroke Card Long-term Follow-Up

Role: collaborator

NCT05489107Unknown

New Local Treatment of Radiation-induced Proctitis

Role: lead

NCT02156778Not ApplicableCompleted

Post-Stroke Disease Management - Stroke Card

Role: collaborator

NCT01801644Not ApplicableCompleted

Neoadjuvant Chemotherapy in Locally Advanced Bladder Cancer

Role: lead

All 6 trials loaded